Recce Pharmaceuticals Limited (ASX:RCE) Secures Approval for Phase 3 Clinical Trial
Recce Pharmaceuticals receives approval for a Phase 3 trial of RECCE® 327 in Indonesia for diabetic foot infections.
Category: Healthcare
Elevate Uranium Limited (ASX:EL8) Updates on Exploration and Development Progress
Elevate Uranium Limited (ASX:EL8) shares progress on exploration and upcoming U-pgrade™ demonstration plant in Namibia.
Saturn Metals Limited (ASX:STN) Reports Fatal Incident at Apollo Hill
Saturn Metals Limited reports a fatal incident at Apollo Hill, prompting a suspension of operations and support for affected personnel.
Verbrec Limited (ASX:VBC) Secures $4.2 Million Electrical Project
Verbrec Limited secures a $4.2 million contract for the Electrical System Redevelopment Project at Inner Harbour, enhancing vital port infrastructure.
Tivan Limited (ASX:TVN) Secures $7.4 Million Grant for Speewah Fluorite Project
Tivan Limited secures a $7.4 million grant for the Speewah Fluorite Project, enhancing Australia’s critical minerals supply chain.
Cynata Therapeutics Limited (ASX:CYP) Secures $8.1 Million Placement
Cynata Therapeutics raises $8.1 million following positive DFU trial results.
CleanSpace Holdings Limited (ASX:CSX) Announces New CEO
CleanSpace Holdings (ASX:CSX) announces Gabrielle O’Carroll as new CEO to drive growth in the respiratory technology sector.
Tuas Limited (ASX:TUA) AGM Highlights Strong Financial Performance
Tuas Limited reports positive Q1 FY25 results and strong growth in mobile services at their AGM.
Forbidden Foods Limited (ASX:FFF) Reports 80% Sales Growth
Forbidden Foods Limited (ASX:FFF) reports a remarkable 80% increase in sales for November 2024, reaching over $500,000.
Acrux Limited (ASX:ACR) Updates Investor Presentation Following Key Announcements
Acrux Limited (ASX:ACR) updates its investor presentation following FDA approval and capital raising efforts.